C O N M E D Corp is a well-established medical technology company that specializes in the development and manufacturing of innovative products for surgical and non-surgical procedures
The company focuses on providing advanced solutions in areas such as orthopedic surgery, endoscopy, and pain management, aiming to enhance patient outcomes and improve healthcare efficiency. Through its commitment to research and development, Conmed creates a portfolio of instruments, devices, and technologies designed to assist healthcare professionals in delivering high-quality care. The company prioritizes collaboration with clinicians to identify unmet needs in the medical field, thereby driving innovation that addresses both current and future healthcare challenges.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSEBDX) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSECNMD) and the best and worst performers in the surgical equipment & consumables - diversified industry.
Medical tech company CONMED (NYSECNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue guidance of $1.36 billion at the midpoint came in 2.7% below analysts’ estimates. Its non-GAAP profit of $1.34 per share was 11.4% above analysts’ consensus estimates.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
